Help the #HuntingtonsDisease research community understand the reasons why you would or would not participate in a drug trial or observational study. Participate in the #ProjectAWARE 2.0 Survey at myHDstory.org or download the app.

🌟#HSG2024 Session Highlight!🌟 🧠Explore the gap between predictive testing & diagnosis for #HuntingtonsDisease, and how to better support brain health. Discover support programs & research such as ENROLL-HD, Change HD & myHDstory®. 👉 Register: bit.ly/Info-HSG2024

ONLINE STUDY: LEAD-HD STATUS: Now Enrolling Register at myHDstory.org or download the mobile app Help researchers create clinically meaningful outcomes for future clinical trials. Sign up today and make your voice heard! #LeadHD

Connect. Learn. Share. Join us in Nashville on Oct 11 for HD Community Research Day, a free event for individuals and families impacted by Huntington’s disease. Learn more or register here: tinyurl.com/2mpb3cuw #HDAwareness #HDWarrior

Thank you, Prilenia, for supporting innovation in HD research as a 2025 Innovator sponsor of the #HDCongress2025, helping bring together researchers, clinicians, and the HD community!

HSGCR is one of our many valued exhibitors this year at the #HDCongress2025. Be sure to visit the exhibit hall to connect with HD advocates, industry leaders, and innovators making an impact in HD.

We’re grateful to Novartis and Neurocrine Biosciences for joining as Innovator Sponsors of the #HDCongress2025. Their partnership reflects the collective commitment to advancing Huntington’s disease research and care.

Thank you to the incredible exhibitors of the #HDCongress2025 who help make the HD Clinical Research Congress possible.

Thank you, Teva Pharmaceuticals, for supporting innovation in HD research as a 2025 Innovator Sponsor of #HDCongress2025. We're just 15 days away until we gather in Nashville!

We’re headed to #HDCongress2025 and look forward to connecting with the HD community. Stop by our table to learn more about SELECT-HD, our clinical trial for WVE-003, our first-in-class, allele-selective oligonucleotide for the treatment of HD. HuntingtonStudyGroup $WVE

Prilenia and @Ferrerforgood will share new data and analyses of #pridopidine’s impact on #Huntingtonsdisease at the HuntingtonStudyGroup (HSG) #HDCongress2025, including new analyses of 2-year pridopidine data following patients not taking antidopaminergic medicines (ADMs) through

We're excited to sponsor & attend the HuntingtonStudyGroup Clinical Research Congress in Nashville this weekend, where we'll connect with the #huntingtonsdisease research community & share a scientific presentation on our investigational #genetherapy candidate AMT-130. #HDCongress2025

Welcoming session at the HD Community Research Day! #HDCongress2025 #HDResearch HuntingtonStudyGroup

Demystifying Clinical Trials Part 1 at #HDCongress2025 #HDResearch HuntingtonStudyGroup

Grateful that doors were opened for global participation and for my acceptance to the 2025 ENGAGE-HD program by HuntingtonStudyGroup. This is an excellent program to train and motivate the next generation practitioners to close gaps in HD research and patient care. #huntingtondisease

There are some really great exhibitors here at #HDCongress2025 #HDResearch HuntingtonStudyGroup instagram.com/p/DPrUnn8kczR/…

It's the opening session for the #HDCongress2025, with over 600 people here and the theme of the conference being "Collaboration and Innovation". The keynote speaker is Merit Cudkowicz who works in the ALS space. #StrongerTogether Help4HD HuntingtonStudyGroup instagram.com/p/DPtmRBXkcPg/…

At the HuntingtonStudyGroup meeting in Nashville! It’s exciting to see the new research/therapies coming for people with Huntington disease. Thanks to the patients and families for their strong involvement in the trials and advocacy 👏🏻And I got to see efurr again 🎉🧠